These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20713251)

  • 21. Targeting intracellular mediators of pattern-recognition receptor signalling to adjuvant vaccination.
    Wales J; Andreakos E; Feldmann M; Foxwell B
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1501-3. PubMed ID: 18031253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Starch microparticles as vaccine adjuvant.
    Rydell N; Stertman L; Sjöholm I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):807-28. PubMed ID: 16296780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvants and delivery systems for viral vaccines--mechanisms and potential.
    Jennings R; Simms JR; Heath AW
    Dev Biol Stand; 1998; 92():19-28. PubMed ID: 9554256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of CpG DNA as a mucosal vaccine adjuvant.
    McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
    Curr Opin Investig Drugs; 2001 Jan; 2(1):35-9. PubMed ID: 11527008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential of CpG oligodeoxynucleotides as mucosal adjuvants.
    McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
    Crit Rev Immunol; 2001; 21(1-3):103-20. PubMed ID: 11642598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between metabolic rate, immune parameters, and growth performance of rainbow trout, Oncorhynchus mykiss (Walbaum), following the injection of a DNA vaccine alone and concurrently with a polyvalent, oil-adjuvanted vaccine.
    Skinner LA; Schulte PM; Balfry SK; McKinley RS; LaPatra SE
    Fish Shellfish Immunol; 2010 Feb; 28(2):387-93. PubMed ID: 20004721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular identification of a danger signal that alerts the immune system to dying cells.
    Shi Y; Evans JE; Rock KL
    Nature; 2003 Oct; 425(6957):516-21. PubMed ID: 14520412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.
    Aucouturier J; Dupuis L; Deville S; Ascarateil S; Ganne V
    Expert Rev Vaccines; 2002 Jun; 1(1):111-8. PubMed ID: 12908518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunology of vaccine adjuvants.
    Ribeiro CM; Schijns VE
    Methods Mol Biol; 2010; 626():1-14. PubMed ID: 20099117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: The regulatory immune system as a target to improve adjuvants and novel vaccines.
    Jiménez-Cortegana C; Poveda C; Cabrera G
    Front Cell Infect Microbiol; 2023; 13():1223689. PubMed ID: 37342243
    [No Abstract]   [Full Text] [Related]  

  • 32. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
    Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
    Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutrients as modulators of immune function.
    Hinds A
    CMAJ; 1991 Jul; 145(1):35. PubMed ID: 2049695
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccine adjuvants revisited.
    Aguilar JC; Rodríguez EG
    Vaccine; 2007 May; 25(19):3752-62. PubMed ID: 17336431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR9 agonists as adjuvants for prophylactic and therapeutic vaccines.
    Daubenberger CA
    Curr Opin Mol Ther; 2007 Feb; 9(1):45-52. PubMed ID: 17330401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
    Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
    Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine with herbal adjuvant--a better cocktail to combat the infection.
    Sakure S; Negi VD; Mitra SK; Nandakumar KS; Chakravortty D
    Vaccine; 2008 Jun; 26(27-28):3387-8. PubMed ID: 18502004
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
    Hem SL; Hogenesch H
    Expert Rev Vaccines; 2007 Oct; 6(5):685-98. PubMed ID: 17931150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.